checkAd

     157  0 Kommentare PDS Biotechnology Announces Conference Call and Webcast for Business Update and Full Year 2023 Financial Results - Seite 3

    Versamune and Infectimune are registered trademarks of PDS Biotechnology Corporation.

    Investor Contact:
    Mike Moyer
    LifeSci Advisors
    Phone +1 (617) 308-4306
    Email: mmoyer@lifesciadvisors.com

    Media Contact:
    Gina Mangiaracina
    6 Degrees
    Phone +1 (917) 797-7904
    Email: gmangiaracina@6degreespr.com


    Aktuelle Themen


    globenewswire
    0 Follower
    Autor folgen

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    PDS Biotechnology Announces Conference Call and Webcast for Business Update and Full Year 2023 Financial Results - Seite 3 PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) - PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and …